US Stock MarketDetailed Quotes

XFOR X4 Pharmaceuticals

Watchlist

0.695
+0.063+9.88%

Close Aug 16 16:00 ET

0.680
-0.015-2.10%

Post 20:01 ET

117.07MMarket Cap5.34P/E (TTM)

X4 Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

563K

Operating revenue

--563K

--0

Cost of revenue

268K

Gross profit

295K

Operating expense

32.50%34.19M

27.25%37.29M

22.08%107.52M

-1.48%25.2M

35.03%27.21M

25.45%25.81M

34.56%29.3M

16.89%88.08M

32.54%25.58M

5.41%20.15M

Selling and administrative expenses

30.13%13.28M

140.78%17.44M

31.40%35.51M

51.26%9.93M

34.56%8.13M

51.19%10.2M

-5.52%7.24M

9.38%27.02M

-8.02%6.56M

1.91%6.04M

Research and development costs

34.06%20.91M

-10.01%19.85M

17.95%72.02M

-19.68%15.27M

35.23%19.08M

12.88%15.6M

56.33%22.06M

20.56%61.06M

56.34%19.01M

6.99%14.11M

Operating profit

-31.36%-33.9M

-27.25%-37.29M

-22.08%-107.52M

1.48%-25.2M

-35.03%-27.21M

-25.45%-25.81M

-34.56%-29.3M

-16.89%-88.08M

-32.54%-25.58M

-5.41%-20.15M

Net non-operating interest income expense

-161.11%-611K

-194.89%-808K

68.34%-1.2M

53.38%-441K

75.50%-246K

74.40%-234K

69.89%-274K

-3.91%-3.77M

-2.60%-946K

-9.37%-1M

Non-operating interest income

71.23%1.57M

27.66%1.07M

1,992.24%4.58M

629.80%1.45M

9,814.29%1.39M

22,750.00%914K

27,733.33%835K

2,090.00%219K

6,500.00%198K

600.00%14K

Non-operating interest expense

89.55%2.18M

68.98%1.87M

44.68%5.78M

64.86%1.89M

60.51%1.63M

25.05%1.15M

21.47%1.11M

9.64%3.99M

23.68%1.14M

10.65%1.02M

Other net income (expense)

522.68%125.36M

-345.42%-13.65M

483.90%7.63M

354.89%6.54M

5,809.98%25.18M

-10,845.65%-29.66M

646.58%5.56M

79.51%-1.99M

74.29%-2.57M

-224.26%-441K

Gain on sale of security

167.70%20.22M

-352.90%-13.76M

315.87%7.07M

432.02%6.33M

--25.16M

-9,013.43%-29.86M

2,990.34%5.44M

564.75%1.7M

460.61%1.19M

----

Special income (charges)

--105M

----

--0

----

105.22%509K

--0

-Less:Impairment of capital assets

----

--0

----

--0

----

-Gain on sale of property,plant,equipment

--105M

----

--0

----

--509K

--0

Other non- operating income (expenses)

-28.71%144K

-14.63%105K

113.20%554K

105.64%212K

103.85%17K

442.37%202K

105.00%123K

-1,085.21%-4.2M

-3,747.57%-3.76M

-495.95%-441K

Income before tax

263.12%90.85M

-115.47%-51.75M

-7.73%-101.09M

34.35%-19.1M

89.45%-2.28M

-162.62%-55.7M

-9.45%-24.02M

-5.82%-93.84M

3.69%-29.09M

-7.07%-21.6M

Income tax

20.00%18K

375.00%19K

178.57%78K

135.71%33K

300.00%26K

275.00%15K

-82.61%4K

64.71%28K

366.67%14K

-750.00%-13K

Net income

263.04%90.83M

-115.51%-51.77M

-7.78%-101.17M

34.27%-19.13M

89.32%-2.31M

-162.64%-55.71M

-9.36%-24.02M

-5.83%-93.87M

3.65%-29.1M

-6.99%-21.59M

Net income continuous Operations

263.04%90.83M

-115.51%-51.77M

-7.78%-101.17M

34.27%-19.13M

89.32%-2.31M

-162.64%-55.71M

-9.36%-24.02M

-5.83%-93.87M

3.65%-29.1M

-6.99%-21.59M

Minority interest income

Net income attributable to the parent company

263.04%90.83M

-115.51%-51.77M

-7.78%-101.17M

34.27%-19.13M

89.32%-2.31M

-162.64%-55.71M

-9.36%-24.02M

-5.83%-93.87M

3.65%-29.1M

-6.99%-21.59M

Preferred stock dividends

Other preferred stock dividends

-81.74%2.55M

287K

Net income attributable to common stockholders

263.04%90.83M

-115.51%-51.77M

-4.93%-101.17M

34.27%-19.13M

89.46%-2.31M

-162.64%-55.71M

0.84%-24.02M

6.07%-96.41M

18.96%-29.1M

-8.42%-21.87M

Basic earnings per share

236.36%0.45

-62.50%-0.26

62.50%-0.57

68.97%-0.09

96.15%-0.01

45.00%-0.33

77.78%-0.16

61.90%-1.52

76.61%-0.29

65.79%-0.26

Diluted earnings per share

236.36%0.45

-62.50%-0.26

62.50%-0.57

68.97%-0.09

96.15%-0.01

45.00%-0.33

77.78%-0.16

61.90%-1.52

76.61%-0.29

65.79%-0.26

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	563K	0	0	0	0	0	0	0	0	0
Operating revenue	--563K	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue	268K					0
Gross profit	295K					0
Operating expense	32.50%34.19M	27.25%37.29M	22.08%107.52M	-1.48%25.2M	35.03%27.21M	25.45%25.81M	34.56%29.3M	16.89%88.08M	32.54%25.58M	5.41%20.15M
Selling and administrative expenses	30.13%13.28M	140.78%17.44M	31.40%35.51M	51.26%9.93M	34.56%8.13M	51.19%10.2M	-5.52%7.24M	9.38%27.02M	-8.02%6.56M	1.91%6.04M
Research and development costs	34.06%20.91M	-10.01%19.85M	17.95%72.02M	-19.68%15.27M	35.23%19.08M	12.88%15.6M	56.33%22.06M	20.56%61.06M	56.34%19.01M	6.99%14.11M
Operating profit	-31.36%-33.9M	-27.25%-37.29M	-22.08%-107.52M	1.48%-25.2M	-35.03%-27.21M	-25.45%-25.81M	-34.56%-29.3M	-16.89%-88.08M	-32.54%-25.58M	-5.41%-20.15M
Net non-operating interest income expense	-161.11%-611K	-194.89%-808K	68.34%-1.2M	53.38%-441K	75.50%-246K	74.40%-234K	69.89%-274K	-3.91%-3.77M	-2.60%-946K	-9.37%-1M
Non-operating interest income	71.23%1.57M	27.66%1.07M	1,992.24%4.58M	629.80%1.45M	9,814.29%1.39M	22,750.00%914K	27,733.33%835K	2,090.00%219K	6,500.00%198K	600.00%14K
Non-operating interest expense	89.55%2.18M	68.98%1.87M	44.68%5.78M	64.86%1.89M	60.51%1.63M	25.05%1.15M	21.47%1.11M	9.64%3.99M	23.68%1.14M	10.65%1.02M
Other net income (expense)	522.68%125.36M	-345.42%-13.65M	483.90%7.63M	354.89%6.54M	5,809.98%25.18M	-10,845.65%-29.66M	646.58%5.56M	79.51%-1.99M	74.29%-2.57M	-224.26%-441K
Gain on sale of security	167.70%20.22M	-352.90%-13.76M	315.87%7.07M	432.02%6.33M	--25.16M	-9,013.43%-29.86M	2,990.34%5.44M	564.75%1.7M	460.61%1.19M	----
Special income (charges)	--105M	----	--0	--0	--0	--0	----	105.22%509K	--0	--0
-Less:Impairment of capital assets	----	----	--0	----	----	----	----	--0	----	----
-Gain on sale of property,plant,equipment	--105M	----	--0	--0	--0	--0	----	--509K	--0	--0
Other non- operating income (expenses)	-28.71%144K	-14.63%105K	113.20%554K	105.64%212K	103.85%17K	442.37%202K	105.00%123K	-1,085.21%-4.2M	-3,747.57%-3.76M	-495.95%-441K
Income before tax	263.12%90.85M	-115.47%-51.75M	-7.73%-101.09M	34.35%-19.1M	89.45%-2.28M	-162.62%-55.7M	-9.45%-24.02M	-5.82%-93.84M	3.69%-29.09M	-7.07%-21.6M
Income tax	20.00%18K	375.00%19K	178.57%78K	135.71%33K	300.00%26K	275.00%15K	-82.61%4K	64.71%28K	366.67%14K	-750.00%-13K
Net income	263.04%90.83M	-115.51%-51.77M	-7.78%-101.17M	34.27%-19.13M	89.32%-2.31M	-162.64%-55.71M	-9.36%-24.02M	-5.83%-93.87M	3.65%-29.1M	-6.99%-21.59M
Net income continuous Operations	263.04%90.83M	-115.51%-51.77M	-7.78%-101.17M	34.27%-19.13M	89.32%-2.31M	-162.64%-55.71M	-9.36%-24.02M	-5.83%-93.87M	3.65%-29.1M	-6.99%-21.59M
Minority interest income
Net income attributable to the parent company	263.04%90.83M	-115.51%-51.77M	-7.78%-101.17M	34.27%-19.13M	89.32%-2.31M	-162.64%-55.71M	-9.36%-24.02M	-5.83%-93.87M	3.65%-29.1M	-6.99%-21.59M
Preferred stock dividends
Other preferred stock dividends			0	0	0			-81.74%2.55M	0	287K
Net income attributable to common stockholders	263.04%90.83M	-115.51%-51.77M	-4.93%-101.17M	34.27%-19.13M	89.46%-2.31M	-162.64%-55.71M	0.84%-24.02M	6.07%-96.41M	18.96%-29.1M	-8.42%-21.87M
Basic earnings per share	236.36%0.45	-62.50%-0.26	62.50%-0.57	68.97%-0.09	96.15%-0.01	45.00%-0.33	77.78%-0.16	61.90%-1.52	76.61%-0.29	65.79%-0.26
Diluted earnings per share	236.36%0.45	-62.50%-0.26	62.50%-0.57	68.97%-0.09	96.15%-0.01	45.00%-0.33	77.78%-0.16	61.90%-1.52	76.61%-0.29	65.79%-0.26
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall